Bichromatic
Imaging with Hemicyanine Fluorophores
Enables Simultaneous Visualization of Non-alcoholic Fatty Liver Disease
and Metastatic Intestinal Cancer
posted on 2022-09-20, 07:08authored byWeijia Xu, Senyao Liu, Zhaoming Chen, Fapu Wu, Wenwen Cao, Yang Tian, Hu Xiong
Simultaneous detection of different diseases via a single
fluorophore
is challenging. We herein report a bichromatic fluorophore named Cy-914 for the simultaneous diagnosis of non-alcoholic fatty
liver disease (NAFLD) and metastatic intestinal cancer by leveraging
its NIR-I/NIR-II dual-color imaging capability. Cy-914 with a pKa of 6.98 exhibits high sensitivity
to pH and viscosity, showing turn-on NIR-I fluorescence at 795 nm
in an acidic tumor microenvironment, meanwhile displaying intense
NIR-II fluorescence at 914/1030 nm under neutral to slightly basic
viscous conditions. Notably, Cy-914 could sensitively
and noninvasively monitor viscosity variations in the progression
of NAFLD. More importantly, it was able to simultaneously visualize
NAFLD (ex/em = 808/1000–1700 nm) and intestinal metastases
(ex/em = 570/810–875 nm) in two independent channels without
spectral cross interference after topical spraying, further improving
fluorescence-guided surgery of tiny metastases less than 3 mm. This
strategy may provide an understanding for developing multi-color fluorophores
for multi-disease diagnosis.